comparemela.com

Latest Breaking News On - Harpoon therapeutics inc - Page 1 : comparemela.com

Merck to Pay as Much as $3 Billion for Eye Treatment Startup

Merck to Pay as Much as $3 Billion for Eye Treatment Startup
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United-kingdom
Kate-bingham
Sabah-meddings
Bloomberg-merck-co
Daiichi-sankyo-co
Eyebiotech-ltd
Prometheus-biosciences-inc
Sv-health-investors
Harpoon-therapeutics-inc
Daiichi-sankyo

Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer

Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Germany
United-states
German
Americans
Boehringer-ingelheim-gmb
Astrazeneca-imfinzi
Jay-bradner
Robert-langreth
Bloomberg-amgen-inc
Harpoon-therapeutics-inc
Merck-co
Amgen

Amgen Drug Wins US Approval for Type of Advanced Lung Cancer

Amgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced lung cancer, providing a badly needed new option for patients when chemotherapy stops working.

Germany
United-states
Americans
German
Boehringer-ingelheim-gmb
Astrazeneca-imfinzi
Robert-langreth
Jay-bradner
Drug-administration
Amgen
Merck-co
Harpoon-therapeutics-inc

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Ashleigh-barreto
Michael-faerm
Mark-rothera
Theravance-inc
Viracta-therapeutics-inc
Stanford-university
Regeneron-pharmaceuticals
Harvard-business-school
Harpoon-therapeutics-inc
Artiva-biotherapeutics-inc
Merrill-lynch
Head-of-investor-relations-corporate-communications

Merck Announces First-Quarter 2024 Financial Results

Sales Reflect Continued Strong Growth in Oncology and Vaccines Total Worldwide Sales Were $15.8 Billion, an Increase of 9% From First Quarter 2023; Excluding the Impact of Foreign Exchange,.

Chicago
Illinois
United-states
Canada
Japan
China
Argentina
Argentine
America
American
Adempas-verquvo
Raludotatug-deruxtecan

vimarsana © 2020. All Rights Reserved.